DR. DAVID M BRISCOE, MB, CHB
Medical Practice at Longwood Ave, Boston, MA

License number
Massachusetts 71574
Category
Medical Practice
Type
Pediatric Nephrology
Address
Address 2
300 Longwood Ave, Boston, MA 02115
6 Pleasant St, Sharon, MA 02067
Phone
(617) 355-6129
(617) 730-0130 (Fax)
(781) 784-0272

Personal information

See more information about DAVID M BRISCOE at radaris.com
Name
Address
Phone
David Briscoe, age 65
6 Pleasant St, Sharon, MA 02067

Professional information

See more information about DAVID M BRISCOE at trustoria.com
David M Briscoe Photo 1
David M Briscoe, Boston MA

David M Briscoe, Boston MA

Specialties:
Pediatric Nephrologist
Address:
300 Longwood Ave, Boston, MA 02115


David Michael Briscoe Photo 2
David Michael Briscoe, Boston MA

David Michael Briscoe, Boston MA

Specialties:
Pediatrics, Pediatric Nephrology, Nephrology
Work:
Children's Hospital
300 Longwood Ave, Boston, MA 02115
Education:
Royal College Of Surgeons In Ireland (1982)


David M Briscoe Photo 3
Dr. David M Briscoe, Boston MA - MD (Doctor of Medicine)

Dr. David M Briscoe, Boston MA - MD (Doctor of Medicine)

Specialties:
Pediatrics
Address:
CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston 02115
(617) 355-6117 (Phone), (617) 738-7066 (Fax)
Childrens Hosp Div Of Nephrlgy
300 Longwood Ave SUITE 5, Boston 02115
(617) 355-6129 (Phone)
Certifications:
Pediatrics, 1994
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
ROYAL COLLEGE OF SURGEONS IN IRELAND / MEDICAL SCHOOL
Ea Hlth Bd Hosps
University of Colorado
Childrens Hospital


David Briscoe Photo 4
Treatment Of Chronic Allograft Rejection With Anti-Angiogenic Agents

Treatment Of Chronic Allograft Rejection With Anti-Angiogenic Agents

US Patent:
6218361, Apr 17, 2001
Filed:
Nov 25, 1998
Appl. No.:
9/200503
Inventors:
David M. Briscoe - Sharon MA
Karen Moulton - Weston MA
Mohamed H. Sayegh - Westwood MA
Assignee:
Children's Medical Center Corporation - Boston MA
International Classification:
A61K 3800, A61K 3812, A61K 3813, A61K 31335, A01N 4320
US Classification:
514 11
Abstract:
The invention relates a method of inhibiting chronic allograft rejection in a subject with an organ transplant. The method comprises administering an effective amount of one or more anti-angiogenic agents to a subject alone or in combination with one or more immunosuppressive agents. The invention provides new and improved methods of inhibiting allograft rejection.


David Briscoe Photo 5
Treatment Of Allograft Rejection With Anti-Angiogenic Agents

Treatment Of Allograft Rejection With Anti-Angiogenic Agents

US Patent:
2001001, Aug 16, 2001
Filed:
Jan 17, 2001
Appl. No.:
09/764323
Inventors:
David Briscoe - Sharon MA, US
Karen Moulton - Weston MA, US
Mohamed Sayegh - Westwood MA, US
International Classification:
A61K038/16, A61K038/13
US Classification:
514/002000, 514/009000
Abstract:
The invention relates a method of inhibiting allograft rejection in a subject with an organ transplant. The method comprises administering an effective amount of one or more anti-angiogenic agents to a subject alone or in combination with one or more immunosuppressive agents. The invention provides new and improved methods of inhibiting allograft rejection.